PG
Paragkumar Gunvantlal Bhavsar
About Paragkumar Gunvantlal Bhavsar
Data last updated:
Paragkumar Gunvantlal Bhavsar is a Director at Brichem Sciences Private Limited (since 2019), Director at Maharshi Pharma Chem Private Limited (since 2014) and Director at Ja Sterile Private Limited (since 2018), and holds 3 more current directorships. The companies operate in Pharma and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹219 Cr; the largest is Brichem Sciences Private Limited at ₹91.35 Cr (FY 2025). Earlier, Paragkumar Gunvantlal Bhavsar was a Director at Ruja Impex Private Limited (2013–2023) and Director at Apister Lifesciences Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Mar 2019 | 2016 | ₹91.35 Cr (FY 2025) | Active | |
| Director | 21 May 2014 | 1998 | ₹68.24 Cr (FY 2023) | Active | |
| Director | 12 Mar 2018 | 2018 | ₹31.15 Cr (FY 2025) | Active | |
| Director | 06 Jun 2017 | 2017 | ₹28.60 Cr (FY 2025) | Active | |
| Director | 13 Dec 2024 | 2024 | Active | ||
| Director | 21 Apr 1999 | 1999 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2013 | 2012 | ₹9.63 Cr (FY 2022) | Active | |
| Director | 06 Nov 2018 | 2017 | ₹73.56 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Paragkumar Gunvantlal Bhavsar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Paragkumar Gunvantlal Bhavsar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragkumar Gunvantlal Bhavsar
Paragkumar Gunvantlal Bhavsar currently holds 6 directorships: Brichem Sciences Private Limited (Director, since 23 Mar 2019, revenue ₹91.35 Cr (FY 2025)); Maharshi Pharma Chem Private Limited (Director, since 21 May 2014, revenue ₹68.24 Cr (FY 2023)); Ja Sterile Private Limited (Director, since 12 Mar 2018, revenue ₹31.15 Cr (FY 2025)); Texas Lifesciences Private Limited (Director, since 06 Jun 2017, revenue ₹28.60 Cr (FY 2025)); Ticop Life Private Limited (Director, since 13 Dec 2024); and 1 more.
Paragkumar Gunvantlal Bhavsar was first appointed on 21 Apr 1999 as Director at Palam Life Sciences Private Limited. The most recent appointment on record is 13 Dec 2024 at Ticop Life Private Limited.
The 4 current companies of Paragkumar Gunvantlal Bhavsar that report revenue have a combined latest revenue of ₹219 Cr: Brichem Sciences Private Limited ₹91.35 Cr (FY 2025); Maharshi Pharma Chem Private Limited ₹68.24 Cr (FY 2023); Ja Sterile Private Limited ₹31.15 Cr (FY 2025); Texas Lifesciences Private Limited ₹28.60 Cr (FY 2025).
Paragkumar Gunvantlal Bhavsar held 2 earlier board appointments: Ruja Impex Private Limited (Director, 25 Jul 2013 to 30 May 2023); Apister Lifesciences Private Limited (Director, 06 Nov 2018 to 22 Jan 2019).
The current boards of Paragkumar Gunvantlal Bhavsar's companies include Aashay Jayantilal Patel (Brichem Sciences Private Limited), Mittalkumar Jagdishbhai Patel (Brichem Sciences Private Limited), Rajeshkumar Becharbhai Gami (Brichem Sciences Private Limited), Hemal Naranbhai Patel (Maharshi Pharma Chem Private Limited), Mitulkumar Sureshbhai Zala (Maharshi Pharma Chem Private Limited), Bharat Nyalchand Mehta (Ja Sterile Private Limited), among others.